Case report: Emergence of dolutegravir resistance in a patient on second-line antiretroviral therapy
Introduction: The integrase strand transfer inhibitor dolutegravir (DTG) has a high genetic barrier to resistance. Only rare cases of resistance to DTG have been reported when it is used as a component of antiretroviral therapy regimens in treatment-experienced patients unless there was prior use of...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Book |
| Published: |
AOSIS,
2020-07-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|